SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-084748
Filing Date
2024-04-02
Accepted
2024-04-02 16:06:55
Documents
13
Period of Report
2024-04-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d821049d8k.htm   iXBRL 8-K 21154
  Complete submission text file 0001193125-24-084748.txt   139070

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adpt-20240401.xsd EX-101.SCH 2874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20240401_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20240401_pre.xml EX-101.PRE 10828
17 EXTRACTED XBRL INSTANCE DOCUMENT d821049d8k_htm.xml XML 3549
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 24814225
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)